Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02513745
Other study ID # CEP 2014-003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2015
Est. completion date May 5, 2017

Study information

Verified date January 2019
Source Carolina Eyecare Physicians, LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nowadays cataract patient's expectations are closer to those of refractive surgery patients. Patients want to be spectacle independent. However, fifteen to twenty percent of cataract surgery patients have from 1.00 to 3.00 diopters (D) of corneal astigmatism which makes achieving spectacle independence unlikely in this patients unless the astigmatism is treated at the time of cataract surgery. Option to treat this astigmatism include corneal or limbal incisions (LRIs), the use of toric intraocular lenses (IOLs) or LASIK. Regardless of the treatment of choice to correct the astigmatism at time of cataract extraction, a treatment plan has to be calculated preoperatively. This planning include: keratometry measurements and the use of a calculator to estimate the treatment and orientation of IOL and/or placement of the LRIs.

New technology has been developed and is widely used. Among this technology, we have the VERION Image Guided System. This system encompasses a reference unit that takes a picture of the eye with the patient in the sitting position creating image of the patient's eye, capturing scleral vessels, limbus and iris features. It measures keratometry as well as the corneal diameter (limbus) and pupil size. The information captured is transferred automatically to its planner where IOL power calculation and astigmatism correction calculation are completed. Additionally, intraoperative wavefront aberrometry has been used in the last couple of years with increase success.


Description:

Nowadays cataract patient's expectations are closer to those of refractive surgery patients. Patients want to be spectacle independent. However, fifteen to twenty percent of cataract surgery patients have from 1.00 to 3.00 diopters (D) of corneal astigmatism which makes achieving spectacle independence unlikely in this patients unless the astigmatism is treated at the time of cataract surgery.

Currently available treatments include corneal or limbal incisions, the use of toric intraocular lenses (IOLs) or LASIK. Limbal relaxing incisions (LRIs) are the most commonly used manual method Traditionally, LRIs have been made manually (with a surgical knife). With the introduction of femtosecond laser to assist during cataract surgery, a new alternative is available for creating corneal incisions. The stability of the LRIs and visual outcomes using toric IOLs have been shown.

Regardless of the treatment of choice to correct the astigmatism at time of cataract extraction, a treatment plan has to be calculated preoperatively. This planning include: keratometry measurements and the use of a calculator to estimate the treatment and orientation of IOL and placement of the LRIs.

Keratometry can be measured using a variety of devices including manual keratometers (i.e. Javal-Shiotz), automated keratometers, corneal topography, and optical biometry ( IOL master and Lenstar).

Once keratometry to be used has been selected, if the treatment of choice are LRIs, a calculator is used to determine the location and size of the LRI. Many nomograms have been developed; the choice of nomogram is the surgeon's prefer one, usually based on prior experience, and their preferred knife. LRIs calculators are available on line. Nomograms specify the location, length, size, and number of incisions based on the patient's age, the type of astigmatism, and the amount of astigmatism correction needed.

If a toric IOL has been chosen then planning the appropriate orientation of the toric IOL is accomplished by using online calculators. The calculator selects the optimal toric power and location based on the keratometry and the surgically induced astigmatism (SIA) values entered by the surgeon.

Intraoperatively, marking the eye and placing the incisions or aligning the toric IOL in the right axis are key steps for the success of astigmatism correction. Marking of the eye can be done using a variety of instruments using ink and it is routinely done with the patient in the upright position to avoid cyclorotation. Once patient is on the table in supine position, axis should be checked once again. Additional suggested methods to mark the eye include taking pictures preoperatively to identify anatomical landmarks similar to iris registration in refractive surgery. The use of iris registration during LASIK was introduced in 2008. Several publications have shown that patients undergoing wavefront-guided LASIK with iris recognition achieved better visual and refractive outcomes compared to conventional LASIK.

Recently, Alcon introduced VERION Image Guided System: Digital Surgical Planning and Positioning Tools. This system encompasses a reference unit that takes a picture of the eye with the patient in the sitting position creating a high-resolution digital image of the patient's eye, capturing scleral vessels, limbus and iris features. It measures keratometry as well as the corneal diameter (limbus) and pupil size. The information captured is then transferred automatically to the planner where additional information including target refraction, manifest refraction, axial length, anterior chamber depth, and lens thickness is entered for IOL power calculation and astigmatism correction planning. Astigmatism correction options include corneal incisions, toric IOL and a combination of both. Intraoperatively, The VERION Digital Marker displays patient information and images from the VERION Reference Unit. Additionally it positions all incision locations and assists with lens alignment in real time while accounting for the variable impact of cyclorotation and patient eye movement. In the OR, it displays a reticle that helps to align the IOL to the axis according the surgical plan. It also helps to position manual LRIs.

Intraoperative wavefront aberrometry has been used in the last couple of years to confirm spherical and toric power as well as lens position. The Optiwave Refractive Analysis (ORA) system can refract the eye in phakic, aphakic, and pseudophakic states at any time during cataract surgery and assists in IOL power selection and recommendations for toric IOL positioning before and after implantation as well as LRIs confirming the surgery plan calculated preoperatively. Furthermore, VerifEye, an ORA hardware upgrade, provides continuous assessment of the patient's eye allowing for more precise measurements; therefore, more accurate results and improved refractive outcomes and VerifEye +, the latest upgrade that provides streaming information on the refractive status and correct IOL positioning through the right ocular of the surgical microscope. This enables the surgeon to visualize all the information without having to look up at the monitor screen during the surgical procedure.

This new technology is an alternative to plan and treat astigmatism at the time of cataract surgery. It could make this treatment easier for less experience surgeons by facilitating the calculations and making the identification of the correct axis easier by reducing the need for manual marks.

The main objective of this study is to evaluate spherical and astigmatism outcomes post routine cataract surgery when the complete VERION Image Guided System packet + ORA System with VerifEye or VerifEye + are used in the treatment of pre-existing astigmatism using toric intraocular lens (IOL) or corneal incisions compared to the surgeon's standard of care.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date May 5, 2017
Est. primary completion date May 5, 2017
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Subject is undergoing bilateral cataract extraction or refractive lens exchange with intraocular lens implantation and astigmatism correction.

- Willing and able to provide written informed consent for participation in the study

- Willing and able to comply with scheduled visits and other study procedures.

Exclusion Criteria:

- Severe preoperative ocular pathology: amblyopia, rubella cataract, proliferative diabetic retinopathy, shallow anterior chamber, macular edema, retinal detachment, aniridia or iris atrophy, uveitis, history of iritis, iris neovascularization, medically uncontrolled glaucoma, microphthalmos or macrophthalmos, optic nerve atrophy, macular degeneration (with anticipated best postoperative visual acuity less than 20/30), advanced glaucomatous damage, etc.

- Uncontrolled diabetes.

- Use of any systemic or topical drug known to interfere with visual performance.

- Contact lens use during the active treatment portion of the trial.

- Any concurrent infectious/non infectious conjunctivitis, keratitis or uveitis.

- Pseudoexfoliation syndrome or any other condition that has the potential to weaken the zonules

- Previous refractive surgery.

- Any clinically significant, serious or severe medical or psychiatric condition that may increase the risk associated with study participation or study device implantation or may interfere with the interpretation of study results.

- Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial.

- Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Conventional
Routine cataract surgery by phacoemulsification before laser-assisted cataract surgery.
Refractive Cataract Suite (Verion + ORA)
Laser-assisted cataract surgery with the digital surgical planning and positioning tools, and intraoperative aberrometry.

Locations

Country Name City State
United States Carolina Eyecare Physicians, LLC Mount Pleasant South Carolina

Sponsors (2)

Lead Sponsor Collaborator
Carolina Eyecare Physicians, LLC Science in Vision

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Residual Refractive Cylinder This is the manifest refractive cylinder measured 3 months after surgery. Note that because cataract surgery has been performed, there is no associated baseline value. Three months
Secondary Residual Mean Spherical Equivalent Refraction This is the mean of the spherical equivalent refraction (sphere + 0.5*cylinder) from each eye. Note that because cataract surgery has been performed, there is no associated baseline value. Three months
Secondary Residual Corneal Astigmatism This is the anterior corneal astigmatism measured through keratometry. Note that because cataract surgery has been performed, there is no associated baseline value. Three months
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A